As for safety, experts interviewed for this story said they are extremely confident in the systems set up to monitor vaccine ...

A dedicated onconephrology service at Brigham and Women’s Hospital has improved kidney outcomes in patients treated for ...

Here's our list of the leaders in Massachusetts tech, biotech and climate tech who aren't just surviving, but moving their ...

UnitedHealth Group CEO Andrew Witty is stepping down from his post for personal reasons and the health care giant says it’s ...

British pharmaceutical giant GlaxoSmithKline announced Wednesday the acquisition of a drug under development to treat a ...

With a neutral sentiment as of May 8, 2025, according to Moneycontrol analysis, GlaxoSmithKline Pharmaceuticals demonstrates ...

In recent years, the U.K.-listed pharma giant has called increasingly on U.S. law firms for its transactional work.

Teos Therapeutics downgraded to Hold after belrestotug failure and GSK deal ending. Read my updated analysis on ITOS stock ...

GSK will buy efimosfermin, a liver disease drug in late-stage trials, for up to $2 billion from U.S. biotechnology firm ...

The NIFTY MIDCAP 150 index saw significant activity in today's trading session, with Cochin Shipyard, AB Capital, and Mazagon ...

Andrew Witty is a business executive well-known for his contributions to the Pharmaceutical and health sectors.

Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death in the United States, most often caused by cigarette smoking or ...